Aztreonam lysinate is able to be administered via inhalation. It is useful in the treatment of pulmonary bacterial infections, particularly gram-negative bacterial infections. Preparation of aztreonam lysinate using α-aztreonam provides an advantageous manufacturing process and a product which has high purity and stability.